Patient-related outcomes with the use of checkpoint inhibitors for the treatment of metastatic non-small cell lung cancer
Transl Lung Cancer Res
.
2018 Apr;7(Suppl 2):S138-S141.
doi: 10.21037/tlcr.2018.03.09.
Authors
Jyoti Malhotra
1
,
Salma K Jabbour
1
Affiliation
1
Rutgers Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, NJ, USA.
PMID:
29782572
PMCID:
PMC5943224
DOI:
10.21037/tlcr.2018.03.09
No abstract available
Publication types
Editorial
Comment